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Abstract: Der nach einer traumatischen Hirnverletzung auftretende Zelltod von Nervenzellen führt zu
einer fortschreitenden Gewebeatrophie und verursacht damit in der Folge eine neurologische Dysfunk-
tion. Fas (CD95/APO-1) und Fas Ligand (FasL/CD95L/APO-1L) sind wichtige Mediatoren des extrin-
sischen apoptotischen Signalweges, die zuvor sowohl in entsprechenden Tierversuchsmodellen als auch
bei hirntraumatisierten Patienten in verletzten Gehirnarealen in erhöhtem Ausmass nachgewiesen wer-
den konnten. In der vorliegenden Studie wurde an ”Knockout” (-/-)-Mäusen, denen ein geschlossenes
Schädel-Hirn-Trauma (SHT) zugeführt wurde, untersucht, ob das Fehlen von Genen, die für entzün-
dungsmodulierende Zytokine kodieren, das Ausmass des Zelltodes und das Auftreten von Fas und FasL
in den intrakraniellen Kompartimenten verändert. Darüber hinaus ist der mögliche Zusammenhang zwis-
chen Zelltod und Entzündung bewertet worden. Zu diesen Zwecken wurden fortlaufende Hirnschnitte bei
Tumor-Nekrose-Faktor/Lymphotoxin- -/- -Mäusen, Interleukin- 6 -/- -Mäusen und ihren entsprechenden
Wildtyp-Kontrollgruppen jeweils 24 Stunden und 7 Tage nach Zufügung eines geschlossenen SHT mit
TUNEL/Hoechst 33342 Doppelfärbung sowie Immunhistochemie eingefärbt und analysiert. 24 Stun-
den nach Traumasetzung zeigte sich das Maximum TUNEL-positiver Zellen im verletzten Kortex, deren
Anzahl auch nach 7 Tagen noch leicht erhöht war. Übereinstimmende Ergebnisse konnten für Fas reg-
istriert werden. FasL dagegen war nach 24 Stunden nur mässig stark erhöht, präsentierte jedoch seinen
Maximalwert nach 7 Tagen. Apoptotische TUNEL-positive Zellen fanden sich grösstenteils in örtlichem
Zusammenhang mit Neuronen und Fas- und FasL-Immunoreaktivität. Allen Mäusegruppen gleich war
das maximale Auftreten von polymorphkernigen Leukozyten und CD11b-positiven Zellen in den verlet-
zten Hemisphären 24 Stunden nach erfolgter Traumatisierung. Die Ergebnisse zeigen, dass Fas und FasL
nach einem geschlossenen SHT eine wichtige Rolle in der neuronalen Apoptose spielen könnten. Zudem
scheint die Aufregulierung von Fas und FasL unabhängig von der Entzündungsreaktion zu sein, da kein
Unterschied zwischen den Zytokin -/- -Mäusen und den Wildtyp-Kontrollmäusen gefunden werden kon-
nte. Neuronal cell death occurring after traumatic brain injury causes progressive tissue atrophy and
consequent neurological dysfunction. Fas (CD95/APO-1) and Fas ligand (FasL/CD95L/APO-1L) are
important mediators of the extrinsic apoptotic pathway and were previously found to be upregulated
in injured brains, in both patients and animal models. In this study, we examined whether the lack of
genes for inflammatory cytokines altered the extent of cell death and expression of Fas and FasL in the
intracranial compartment in knockout (-/-) mice subjected to closed head injury (CHI). Furthermore, the
possible interrelation between cell death and inflammation was assessed. Consecutive brain sections of tu-
mor necrosis factor/lymphotoxin- -/- and interleukin-6 -/- mice and respective wild type littermates were
analyzed at 24 hours and 7 days after CHI using TUNEL/ Hoechst 33342 double staining and immuno-
histochemistry. The results demonstrate a peak incidence of TUNEL positive cells in the injured cortex
at 24 hours that remained slightly elevated at 7 days and coincided with maximal Fas expression. FasL
was only moderately increased at 24 hours and showed maximal expression at 7days. Apoptotic TUNEL
positive cells mostly co-localized with neurons and with Fas- and FasL immunoreactivity. The amount
of accumulated polymorphonuclear leukocytes (PMNs) and CD11b positive cells was uniformly maximal
in the injured hemispheres at 24 hours. We show strong evidence that Fas and FasL might be involved
in neuronal apoptosis after CHI. Furthermore, Fas- and FasL upregulation seems to be independent of
neuroinflammation since no differences were found between cytokine -/- and wild type mice.
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1. Summary 
  
 
 
 Neuronal cell death occurring after traumatic brain injury causes progressive 
tissue atrophy and consequent neurological dysfunction. Fas (CD95/APO-1) and Fas 
ligand (FasL/CD95L/APO-1L) are important mediators of the extrinsic apoptotic 
pathway and were previously found to be upregulated in injured brains, in both 
patients and animal models. In this study, we examined whether the lack of genes for 
inflammatory cytokines altered the extent of cell death and expression of Fas and 
FasL in the intracranial compartment in knockout (/) mice subjected to closed head 
injury (CHI). Furthermore, the possible interrelation between cell death and 
inflammation was assessed. Consecutive brain sections of tumor necrosis 
factor/lymphotoxin- / and interleukin-6 / mice and respective wild type 
littermates were analyzed at 24 hours and 7 days after CHI using TUNEL/Hoechst 
33342 double staining and immunohistochemistry. The results demonstrate a peak 
incidence of TUNEL positive cells in the injured cortex at 24 hours that remained 
slightly elevated at 7 days and coincided with maximal Fas expression. FasL was 
only moderately increased at 24 hours and showed maximal expression at 7days. 
Apoptotic TUNEL positive cells mostly co-localized with neurons and with Fas- and 
FasL immunoreactivity. The amount of accumulated polymorphonuclear leukocytes 
(PMNs) and CD11b positive cells was uniformly maximal in the injured hemispheres 
at 24 hours. We show strong evidence that Fas and FasL might be involved in 
neuronal apoptosis after CHI. Furthermore, Fas- and FasL upregulation seems to be 
independent of neuroinflammation since no differences were found between  
cytokine / and wild type mice. 
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2. Introduction 
  
 
 
2.1. Epidemiology 
 Traumatic brain injury (TBI) represents the leading cause of death and residual 
neurological impairment in young patients under the age of 45 years (Marshall, 2000) 
in industrialized nations. Despite advances in research and improved neurointensive 
care in the last decade, the clinical outcome of severely head-injured patients is still 
poor (Graham et al., 2000; Maas et al., 2000; Marshall, 2000; Koponen et al., 2002). 
The mortality of TBI remains as high as 35% to 40% and persistent disabilities affect 
all aspects of familiar, social and economical life (Graham et al., 2000; Maas et al., 
2000; Marshall, 2000; Koponen et al., 2002). 
 
2.2. Primary and secondary brain injury 
 The extent of brain damage is determined by primary and secondary injuries. 
The primary injury to the central nervous system (CNS) is a result of the mechanical 
forces applied to the skull and brain at the moment of impact (e.g. the directly 
contused cortex), whereas secondary injuries are initiated in the course of trauma as 
a consequence of complicated processes (e.g. deeper cortical layers beneath or 
other anatomical structures nearby the site of trauma), leading to dysfunction of the 
blood-brain barrier (BBB), induction of cerebral edema and intracranial hypertension 
(Baethmann et al., 1988; Graham et al., 2000; Maas et al., 2000). Evidence of 
secondary brain injury has been found at autopsy in 70% to 90% of fatally head-injured 
patients. Secondary insults are induced in large parts by a profound host-mediated 
inflammatory response within the intracranial compartment (Baethmann et al., 1988; 
Ghirnikar et al., 1998; Neugebauer et al., 2000; Morganti-Kossman et al., 2002). 
Among the crucial endogenous mediators of neuroinflammation are proinflammatory 
cytokines (Neugebauer et al., 2000; Morganti-Kossman et al., 2002), chemokines 
(Ransohoff, 2002) and complement anaphylatoxins (Stahel et al., 1998) which induce 
chemotaxis of blood-derived leukocytes across the BBB into the subarachnoid space 
(Holmin et al., 1998; Ransohoff and Tani, 1998). These recruited inflammatory cells 
further contribute to the development of secondary brain damage by exacerbating 
  3 
and perpetuating the inflammatory response in the CNS, e.g. through the oxidative 
burst of neutrophils associated with the release of proteolytic enzymes (Schoettle et al., 
1990; Zhuang et al., 1993). Endogenous mediators released in the injured brain have 
been shown to cause delayed neuronal cell death by induction of apoptosis 
(programmed cell death; PCD) in the posttraumatic course of brain injury (Rink et al., 
1995; Yakovlev et al., 1997; Beer et al., 2000; Clark et al., 2000a). Due to the severe 
adverse effects of these secondary neuropathological events, recent efforts in 
experimental and clinical neurotrauma research have been aimed at elucidating the 
underlying cellular and molecular mechanisms (McIntosh et al., 1998; Bullock et al., 
1999). 
 
2.3. Apoptosis and necrosis 
 Apoptosis is a naturally occurring process of cell suicide that plays a crucial role 
in the development and maintenance of multicellular organisms by eliminating 
superfluous or unwanted cells (Schwartz and Osborne, 1993; Nagata, 1997; Nagata, 
1999; Tschopp et al., 1999; Bredesen, 2000). Apoptosis occurs during development, 
normal cell turnover, hormone-induced tissue atrophy and pathological processes 
such as neurodegenerative diseases (French et al., 1996). Cells undergoing 
apoptosis show characteristic morphological changes including shrinkage of the cell 
and its nucleus, plasma membrane blebbing, chromatin condensation and DNA 
fragmentation (Nagata, 1999; Bredesen, 2000). All mammalian cells appear to 
constitutively express the basic machinery that mediates apoptotic cell death (e.g. a 
family of cysteine proteases, termed caspases), but the initiation of apoptosis is 
carefully regulated. Signals as diverse as viral infections, extracellular survival 
factors, cell interactions and hormones may act to either suppress or promote the 
activation of the death program (Tschopp et al., 1999). Physiological apoptotic cell 
death is, however, though crucial for tissue remodeling and development and is 
characterized by maintenance of the cellular membrane integrity, DNA fragmentation, 
chromatine condensation and cell shrinkage, with ultimative degradation of the cell 
into membranous vesicles. Apoptotic cell bodies are then rapidly phagocytozed by 
immunocompetent cells (Schwartz and Osborne, 1993; Nagata, 1997; Nagata, 1999; 
Tschopp et al., 1999; Bredesen, 2000). 
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Accumulated evidence strongly suggests that apoptosis contributes to neuronal cell 
death in a variety of neurodegenerative and neuroinflammatory diseases (Robertson 
et al., 2000; Jin K. et al., 2001; Puig and Ferrer, 2002). Induction of cell death can 
mainly occur by two distinct mechanisms which are differentiated by morphological 
characteristics and different pathophysiological pathways. On the one hand, neurons 
can undergo necrotic cell death in an early phase after brain injury, due to direct 
mechanical damage to the membranes and the cytoskeleton with consecutive 
disturbances of ionic homeostasis and energy metabolism due to decreased 
intracellular adenosine triphosphate (ATP) levels. On the other hand, neuronal 
apoptosis can occur; an active process involving protein synthesis of endogenous 
nucleases. Table 1 shows important morphological and biochemical features and the 
physiological significance of apoptosis and necrosis. 
 
Distinct signaling pathways of PCD have been described as the intrinsic and extrinsic 
pathways of apoptosis (Bredesen, 2000) and evidence exists for the involvement of 
both in neuronal cell death following brain injury. The intrinsic pathway is 
characterized by mitochondrial release of cytochrome C into the cytosol and 
consecutive activation of caspases which ultimately lead to apoptotic cell death 
(Sullivan et al., 2002). The extrinsic pathway is initiated by the binding of Fas with 
either its ligand (FasL) or its agonistic anti-Fas antibody (Suda and Nagata, 1994; 
Becher et al., 1998; Martin-Villalba et al., 1999; Felderhoff-Mueser et al., 2000) and is 
mediated by extracellular death factors such as FasL, IL-18, granzymes, tumor 
necrosis factor (TNF) and other members of the TNF-family which correspond to 
enzymes released by natural killer cells (Irmler et al., 1995). Ligand-binding to 
specific receptors that are expressed on the cell surface (death receptors) activates 
intracellular death domains (Schwartz and Osborne, 1993; Chinnaiyan et al., 1995; 
Nagata, 1999; Bredesen, 2000) which are capable of triggering a cascade of cysteine 
proteases (caspases; interleukin-1-converting enzyme related enzymes) whose 
activity is essential for almost all pathways of apoptosis (Thornberry and Lazebnik, 
1998; Tschopp et al., 1999; Bredesen, 2000). Caspase-mediated signal transduction 
leads to cleavage of DNA fragmentation factor-45 into a specific caspase activated 
DNase, which causes degradation of chromosomal DNA (Liu et al., 1997). 
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2.4. The Fas/FasL system 
 The Fas/FasL system has been thoroughly characterized in recent years and 
was determined to be a key regulator of apoptosis (Schwartz and Osborne, 1993; 
Nagata, 1997; Nagata, 1999; Tschopp et al., 1999; Bredesen, 2000). Fas is a type I 
transmembrane receptor glycoprotein belonging to the nerve growth factor 
(NGF)/TNF/lymphotoxin (LT)- receptor family (Nagata and Golstein, 1995; Cheema 
et al., 1999; Nagata, 1999; Rosenbaum et al., 2000). Fas expression on cell surfaces 
has been described in various immune cells (such as T cells) as well as in neuronal 
and glial cells (French et al., 1996; Choi et al. 1999). FasL, the ligand for Fas, is a 
type II membrane protein of the TNF family. Constitutive expression of Fas and FasL 
within normal brain has been previously shown in humans and rodents (Bechmann  
et al., 1999; Park et al., 1998) and its upregulation was demonstrated in various 
neuropathologies including TBI (Dowling et al., 1996; D'Souza et al., 1996; Saas et al., 
1997; Sabelko et al., 1997; Waldner et al., 1997; Zipp et al., 1997). FasL is also 
constitutively expressed on immune cells (e.g. T cells) and resident cells of the CNS 
such as neurons and glia (French et al., 1996; Choi et al., 1999). The 
transmembrane Fas molecule can be assembled to a soluble form (sFas) by 
alternative splicing (Cascino et al., 1995). Although the functional role of sFas 
remains unclear up to date, its detection in experimental model systems has been 
proven to be useful as a marker for activation of the Fas/FasL system. 
 
Fas-mediated apoptosis is tightly controlled by regulatory molecules such as bcl-2 
and p53. The proto-oncogene bcl-2 has been shown to block caspase induced PCD 
in vivo (Yang et al., 1997) and recent data suggest an important role for bcl-2 in 
neuronal survival in models of neuropathology, based on experimental data with 
overexpression of human bcl-2 in transgenic mice (Raghupathi et al., 1998). Elevated 
concentrations of sFas and FasL were previously detected in human cerebrospinal 
fluid (CSF) after severe TBI (Ertel et al., 1997; Lenzlinger et al., 2002). Particularly, 
earlier results from our laboratory showed that a prolonged release of sFas in the 
CSF of patients with severe head trauma strongly correlates with the presence of 
neuron-specific enolase (NSE), a marker of neuronal damage. This supports the 
hypothesis that Fas plays a potential role in the mechanisms of neuronal apoptosis 
(Lenzlinger et al., 2002). 
 
  6 
Following controlled cortical impact injury, the increased expression of Fas and FasL 
was identified on cortical neurons and astrocytes (Beer et al., 2000; Beer et al., 
2001). Interestingly, the activation of Fas, caspase-3 and -8 was found temporarily, 
associated in response to focal brain damage, suggesting downstream involvement 
of the extrinsic pathway of apoptosis (Keane et al., 2001; Qiu et al., 2002). 
 
2.5. The role of apoptosis in neurotrauma 
 Over the past few years, the mechanisms of neuronal cell death after TBI have 
received increased attention, particularly due to high vulnerability of neurons to 
chronic degeneration. Neuronal cell death caused by trauma is a complex 
phenomenon possibly resulting from the simultaneous activation of different 
molecular cascades in response to trauma which remain effective for a long time 
period, provoking progressive tissue atrophy and neurological impairment (Smith et al., 
1997; Conti et al., 1998; Fox et al., 1998). Among these, the release of both 
excitatory amino acids, resulting in excitotoxic cell death, and reactive oxygen 
species, which induce mitochondrial dysfunction and consequent energy failure, have 
been well recognized as causes of delayed neuronal death (Mukhin et al., 1996). 
Evidence for apoptotic and necrotic cell death of neurons and glial cells has been 
reported in the brain of rodents subjected to fluid percussion injury and controlled 
cortical impact injury (Rink A. et al., 1995; Conti et al., 1998; Kaya et al., 1999; Clark 
et al., 2000a) as well as in head trauma patients (reviewed in: Raghupathi et al., 
2000). Within the cascade of apoptotic cell death, the involvement of the Fas/FasL 
system, the tumor suppressor gene p53, caspases and anti-apoptotic factors like  
bcl-2 has been reported in various experimental brain injury models as well as in 
human TBI (Clark et al., 1997a; Clark et al., 2000b; Ertel et al., 1997; Napieralski et al., 
1999; Grosjean et al., 2001; Harter et al., 2001; Keane et al., 2001; Yakovlev et al., 
2001; Lenzlinger et al., 2002; Raghupathi et al., 2002). 
 
2.6. The role of inflammation in neurotrauma 
 It is a matter of controversy whether cerebral inflammation initiated after TBI 
contributes to neurodegeneration or rather to the processes of tissue repair 
(reviewed in: Morganti-Kossmann et al., 2001; Nagata and Golstein, 2001). Over the 
past decade, the profound cerebral inflammatory response following clinical or 
  7 
experimental TBI has been extensively described (Schoettle et al., 1990; Fan et al., 
1996; Lassmann, 1997; Stahel et al., 1998; Penkowa et al., 1999; Sherwood and 
Prough, 2000; Morganti-Kossmann et al., 2000; Morganti-Kossmann et al., 2002). In 
particular, the role of the cytokines TNF (Taupin et al., 1993b; Morganti-Kossmann  
et al., 1997; Shohami et al., 1999; Sullivan et al., 1999; Venters et al., 2000), 
interleukin (IL)-6 (Woodroofe et al., 1991; Taupin et al., 1993a and 1993b) and other 
immune mediators (Rothwell and Hopkins, 1995; Sei et al., 1995; Holmin et al., 1997; 
Feuerstein et al., 1998; Ghirnikar et al., 1998; Morganti-Kossmann et al., 2000) has 
been the focus of several studies. 
 
Although apoptosis is considered to be a process of cell death independent from 
immunoactivation, apoptotic neuronal cell death has been observed at points in time 
which corresponded to the elevation of intracerebral cytokine production after 
experimental head injury in mice (Grosjean et al., 2001; Morganti-Kossman et al., 
2002). Whether or not inflammatory mediators can be considered potential factors 
which mediate neuronal cell death after brain injury is still awaiting further 
experimental evidence. In a model of controlled cortical impact injury, expression of 
both Fas and FasL have been identified on neurons and microglial cells. Fas- as well 
as FasL immunoreactivity overlapped with the regions displaying the highest 
distribution of TUNEL positive cells, as a sign of PCD-mediated DNA fragmentation 
(Grosjean et al., 2001). Further downstream in the apoptotic cascade, the activation 
of poly-ADP-ribosesynthase, an enzyme that mediates DNA repair, has been found 
early (30 minutes) in the injured cortex and has been shown to be cleaved later on 
(one week) and to inhibit delayed repair of damaged DNA (LaPlaca et al., 1999). 
 
The structural homology of Fas- and TNF receptors, together with the existence of a 
common intracellular apoptotic cascade, suggests a potential link between cytokines 
and cell death. In support of this is the evidence that cytokines such as TNF and IL-6 
have the ability to modulate Fas and FasL expression in cultured astrocytes (Choi et al., 
1999). In a model of CHI, neurotoxic properties have been attributed to TNF since its 
elevation in the brain was associated with tissue damage, edema, neurological 
impairment and BBB dysfunction. These adverse effects were attenuated by 
therapeutical application of agents neutralizing TNF action (reviewed in: Shohami et al., 
1999). However, more recently, the use of TNF /, TNF/LT- double / or TNF 
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receptor / mice in models of focal brain injury have raised conflicting results as 
novel neuroprotective functions have been ascribed to TNF (Scherbel et al., 1999; 
Sullivan et al., 1999; Stahel et al., 2000). This conflict is somehow resolved when the 
temporal changes in expression and effects are considered (reviewed in: Shohami et al., 
1999; Morganti-Kossmann et al., 2001). TNF has a dual activity, being detrimental at 
the early and protective at the late phase of the posttraumatic period. As opposed to 
TNF, IL-6 has been shown to possess a protective role for the cells of the nervous 
system, either due to intrinsic neurotrophic properties or through the induction of 
NGF and the inhibitory action of potentially neurotoxic cytokines such as TNF 
(Aderka et al., 1989; Hama et al., 1989; Kossmann et al., 1996). 
 
2.7. Aim of the study 
 Despite the vast amount of evidence of both apoptotic events and inflammation 
occurring in the intracranial compartment after TBI, the exact pathophysiological role 
of Fas-mediated apoptosis and the relation to neuroinflammation after brain injury 
remain controversial to date. The present study was designed to investigate whether 
the lack of TNF, LT- or IL-6 gene expression has an impact on neuronal cell death, 
leukocyte infiltration and time profile of both Fas- and FasL protein synthesis in the 
brain of cytokine / mice subjected to CHI. We focused on the following questions: 
 
1. Which macroscopical and histological characteristics could be found in the injured 
mice brains after experimental CHI? 
2. Which brain regions were most affected by CHI? 
3. Which cell types showed apoptosis and which cells were involved in 
neuroinflammation following trauma? 
4. How did neuronal apoptosis present itself in the mice brains after CHI? 
5. What was the regional and temporal cerebral expression of Fas- and FasL 
proteins before and after CHI? 
6. What was the regional and temporal progression of both apoptosis and 
inflammation in the mice brains? 
7. Can a correlation between apoptosis and neuroinflammation be found when 
comparing / mice lacking the cytokines TNF, LT- or IL-6 to their corresponding 
wild type littermates? 
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3. Materials and Methods 
  
 
 
3.1. Animals 
 Mice double-deficient in genes for TNF and LT- (TNF/LT- /) or deficient in 
the IL-6 gene (IL-6 /) and their corresponding wild type littermates were provided 
by H.-P. Eugster (Eugster et al., 1996) and M. Kopf (Kopf et al., 1994). The    
TNF/LT- / mice were from a mixed C57BL/6x129Sv/Ev (B6x129) genetic 
background (Eugster et al., 1996), whereas the IL-6 / animals were backcrossed 
for ten generations to a C57BL/6 (B6) background (M. Kopf, personal 
communication). B6x129 (n = 7) mice were used as control for the TNF/LT- /      
(n = 7) mice and B6 (n = 8) mice as control for the IL-6 / (n = 7) mice.            
Sham-operated mice (n = 4, one for every genetic group) and normal wild type mice 
(n = 4) were used as control animals. All mice used in this study (n = 37) were males 
aged eight to 16 weeks, with an average weight of 28 g to 32 g. They were bred in a 
specific pathogen-free environment, kept under standard conditions of temperature 
and light in cages of four to six animals and fed with food and water ad libitum. The 
animal experiments were performed in accordance with the guidelines of the 
Institutional Animal Care Committee of the Hebrew University of Jerusalem, Israel. 
 
3.2. Experimental brain injury 
 Experimental CHI was performed in mice (total n = 29) as previously described 
by Chen et al. (1996). In brief, mice were anesthetized with ether and their skull was 
exposed by a longitudinal incision of the skin. A focal trauma was delivered to the 
closed skull of the left hemisphere 2 mm lateral to the midline in the midcoronal plane 
using an electric weight drop device with a metal rod of 333 g falling from a height of 
2 cm (Fig. 1 A). A silicone tip of 3 mm diameter was fixed at the end of the impacting 
rod in order to avoid penetrating skull fractures (Fig. 1 B). After injury, mice received 
temporary oxygen support with 95% O2 until awake and were then brought back to 
their cages, with food and water ad libitum. Sham-operated mice were treated the 
same way as the injured animals but were not subjected to CHI. For histology, 
animals were sacrificed by decapitation under ether anesthesia at 24 hours and 7 days 
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following CHI. The brains were immediately removed, both hemispheres separated, 
snap-frozen in liquid nitrogen, embedded in OCT compound (Tissue-Tek, Miles Inc., 
Elkhart, IN, USA) and stored at -70°C until further analysis. Sham-operated mice 
were sacrificed at 24 hours after sham operation and their brains were processed as 
mentioned above. 
 
3.3. Cryosections and H&E staining 
 For histology, the frozen brains were cut into adjacent serial 10 m coronal 
sections on a microtome (Leica Microsystems GmbH, Nussloch, Germany), in the 
midcoronal plane. Three independent series of seven serial coronal sections of both 
the left injured and right contralateral hemispheres were performed on brains of 
cytokine / mice and their corresponding wild type littermates after CHI (t = 24 hours, 
total n = 13; t = 7 days, total n = 16), sham-operated (t = 24 hours, n = 4) and normal 
wild type (n = 4) mice. Figure 2 shows a representative coronal view of the ipsilateral 
hemisphere of a B6 / mouse at 24 hours after experimental CHI during the process 
of performing the sections. Every first section was double-stained with terminal 
deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling 
(TUNEL)/bisbenzimide Hoechst 33342 fluorochrome (HO33342) and every second 
section was stained with Hematoxylin and Eosin (H&E), in order to study morphologic 
alterations at cellular and tissue level. Every third to seventh section underwent IHC 
using the respective antibodies as described below. The tissue sections were 
analyzed simultaneously in order to allow direct comparison of the stainings in the 
different animal groups at different points in time. 
 
For H&E staining, the sections were air-dried, stained in hematoxylin solution for       
5 minutes at room temperature (RT), washed briefly in running tap water and rinsed 
in 96% ethanol (BDH Laboratory Supplies, Poole, Great Britain) for 2 minutes. The 
sections were then counterstained in eosin solution for 30 seconds, dehydrated 
through 70%, 96% and two changes of absolute ethanol for 5 minutes each, cleared 
in Histo-Clear (Brunschweig Chemie, Basle, Switzerland) and embedded with Eukitt 
(O. Kindler GmbH, Freiburg, Germany). 
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3.4. TUNEL- and Hoechst 33342 double staining 
 To assess intracranial cell death, DNA fragmentation was visualized using the  
in situ cell death detection kit fluorescein (Roche Applied Science, Rotkreuz, 
Switzerland), which is based on the TUNEL histochemistry technique developed by 
Gavrieli et al. (1992). The protocol of the kit was used with minor modifications as 
described below. Briefly, the sections were fixed in 10% neutral buffered 
formaldehyde solution in phosphate-buffered saline (PBS) for 10 minutes at RT, 
differenciated in 2:1 ethanol:acetic acid solution for 5 minutes at -20°C and 
permeabilized in 3% Triton X-100 in PBS for 60 minutes at RT. The sections were 
then incubated in equilibration buffer (30 mM Tris pH 7.2, 140 mM cacodylate sodium 
salt, 1 mM CoCl2, in dH2O) of the TdT enzyme for 20 minutes at RT. Labeling was 
performed in humidified chambers by the application of the TUNEL reaction mixture 
for 90 minutes at 37°C. To visualize the total amount of cells, HO33342 (Calbiochem, 
San Diego, CA, USA), an UV-excited blue bisbenzimidazole dye which selectively 
intercalates into A-T rich regions of DNA and therefore stains all nuclei (Pollack and 
Ciancio 1990), was added simultaneously to the TUNEL mixture. This dye is often 
used to distinguish condensed pycnotic nuclei in apoptotic cells. Finally, the sections 
were mounted with De Pe X (BDH Laboratory Supplies, Poole, Great Britain). Both 
TUNEL- and HO33342 positive cells were then visualized by fluorescence 
microscopy using an Olympus BH-2 microscope (Olympus Optical Co., Hamburg, 
Germany). For negative controls, the terminal TdT enzyme was omitted. TUNEL 
positive cells were differentiated as being apoptotic or non apoptotic based on 
specific verification of two or more of the classic morphological hallmarks of 
apoptosis: chromatin condensation and margination, nuclear shrinkage and 
fragmentation, membrane blebbing and the formation of apoptotic bodies. TUNEL 
positive cells showing nuclei with diffuse staining and without apoptotic morphology 
were considered to be necrotic. 
 
3.5. Immunohistochemistry 
 Immunohistochemistry (IHC) was carried out on sections of both ipsi- and 
contralateral hemispheres of cytokine deficient / and wild type mice after CHI        
(t = 24 hours, total n = 13; t = 7 days, total n = 16), after sham operation (t = 24 hours, 
n = 4) and on sections of normal wild type mice brains (n = 4). In brief, the sections 
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were fixed in absolute acetone (Riedel-de Ha¸n, Seelze, Germany) for 5 minutes at RT, 
blocked in a buffer containing 4% cows milk and 2% horse serum in PBS for 1 hour 
at RT and incubated with the primary antibodies diluted in 2% cows milk in PBS as 
described below. Neurons were identified by using a mouse monoclonal anti-neuronal 
nuclei (NeuN, 1:100; Chemicon, Temecula, CA, USA) antibody. For immunolabeling 
with Fas or FasL, sections were incubated overnight at 4°C with rabbit polyclonal 
anti-mouse Fas antibody (M-20, 1:1000; Santa Cruz Biotechnology, CA, USA) or with 
goat polyclonal anti-mouse FasL antibody (N-20, 1:750; Santa Cruz Biotechnology, 
CA, USA), respectively. Infiltrating polymorphonuclear leukocytes (PMNs) were 
stained using a rat anti-mouse polymorphonuclear leukocyte antibody (1:100; 
BioSource, Camarillo, CA, USA). Macrophages and activated microglia were 
visualized using a rat monoclonal anti-mouse complement receptor type 3 antibody 
(CD11b, 1:100; Pharmingen, San Diego, CA, USA). Detection of the primary 
antibodies was performed using peroxidase-coupled secondary antibodies and the 
Vectastain ABC kit (Vector Labs, Burlingame, CA, USA) with 3,3-diaminobenzidine 
tetrahydrochloride as chromogen. The secondary biotinylated antibodies were from 
Vector or BioSource and were applied for 1 hour at RT at various dilutions of 1:200 
(anti-mouse IgG), 1:400 (anti-rabbit IgG and anti-goat IgG) and 1:500 (anti-rat IgG) in 
2% cows milk in PBS. For negative controls, the primary antibody was omitted and 
the sections were incubated with blocking buffer. Methyl green was used as 
counterstain on all sections. 
 
3.6. Analysis of Fas- and FasL expression 
 For assessment of intracranial Fas- and FasL expression, leukocyte 
accumulation and degeneration of neurons after trauma IHC was performed on brain 
sections at 24 hours and 7 days following CHI as described above. Fas- and FasL 
positive cells were scored in the cortex and hippocampus for each animal on both the 
side of injury (left) and on the contralateral side (right) by counting the cells at 20X 
magnification (final magnification 250X) using a stereological grid in the ocular lens of 
the microscope. For each section, the counts were performed in four randomly 
selected fields of 0.4 mm2 in the deeper cortical layers (below the directly contused 
tissue) and in the CA2/3 hippocampal regions. The corresponding total cell number 
was determined by counting all methyl green counterstained cells in the identical 
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fields. The level of Fas- and FasL expression in defined areas of the cortex and 
hippocampus was assigned to one of four categories: 
 
 = no staining or occasional weak staining 
+ = few Fas-/FasL positive cells (<10%) 
++ = 10% to 50% Fas-/FasL positive cells 
+++ = 50% to 90% Fas-/FasL positive cells 
++++ = 90% to 100% Fas-/FasL positive cells. 
 
3.7. Analysis of leukocyte accumulation and neurodegeneration 
 In order to determine the extent of leukocyte accumulation and of degeneration 
of neurons in the injured hemispheres, PMNs and CD11b- and NeuN positive cells 
were quantified on consecutive sections as described above. For each section, the 
counts were again performed in four randomly selected fields of 0.4 mm2 in the 
region of cortical layers below the directly contused area. The corresponding total cell 
number was determined by counting all methyl green counterstained cells. The 
percentages of PMNs and CD11b positive cells were calculated and expressed as 
mean value ± standard deviation. 
 
3.8. Statistical analysis 
 Statistical significance of differences between the mouse groups was analyzed 
using the unpaired two-sided Student's t-test. A probability of p<0.05 was considered 
statistically significant. 
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4. Results 
  
 
 
4.1. Regional and temporal distribution of DNA fragmentation 
 Cell death was assessed by TUNEL staining (Fig. 3 A, C, E and G) while the 
total number of cells were visualized by simultaneous staining of all nuclei with 
HO33342 dye (Fig. 3 B, D, F and H). Brain sections of both normal wild type mice 
and sham-operated control mice (24 hours following skin incision) showed no 
significant amount of TUNEL positive cells (Fig. 3 A). In addition, HO33342- (Fig. 3 B) 
and H&E staining (not shown) of these brain sections demonstrated normal tissue 
morphology. However, at 24 hours after CHI, the injured parieto-temporal cortex was 
characterized by the presence of a striking amount of TUNEL positive cells, including 
the deeper, not directly contused cortical layers (Fig. 3 C, arrowheads), being of 
similar extent in both / and wild type mice. HO33342 staining also revealed the 
presence of condensed nuclei within the deeper cortical layers (Fig. 3 D, 
arrowheads), suggesting nuclear condensation, one of the morphological hallmarks 
of apoptosis. Interestingly, we also found a few TUNEL positive cells in the ipsilateral 
hippocampus within the CA2/3 regions (Fig. 3 E) at 24 hours after CHI, whereas at   
7 days TUNEL positive cells were virtually undetectable in the hippocampus (Fig. 5 I). 
The amount of TUNEL positive cells in the injured cortex generally decreased at       
7 days after CHI (Fig. 3 G). However, at this point in time we found pronounced 
morphological alterations within the ipsilateral hemisphere such as enlarged 
ventricles and increased size of the contusion cavities (Fig. 3 H). Generally, the 
contusion cavities expanded into deeper cortical layers at 7 days post injury (Fig. 3 H) 
as a result of ongoing tissue degradation. TUNEL positive cells were practically not 
found in other ipsilateral brain regions or in the contralateral hemisphere, neither at 
24 hours nor at 7 days after CHI (not shown). There were no evident signals when 
the TdT enzyme was omitted (negative control) in TUNEL experiments (not shown). 
 
4.2. Morphological characterization of apoptosis in the injured hemisphere 
 In order to determine whether cell death after CHI results from necrosis or 
apoptosis, brain sections from the injured hemispheres were double-stained with 
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TUNEL staining/HO33342 dye. Subsequently, the tissues were analyzed in identical 
fields for both stainings, based on selection criteria of nuclear morphology for 
apoptosis, as mentioned above. Apoptotic cells were found in all ipsilateral cortical 
layers near the site of trauma in all mice groups. Figure 4 shows representative 
photomicrographs of the injured cortical layer III of IL-6 / mice. At 24 hours after 
CHI, most TUNEL positive cells depicted the characteristic morphological hallmarks 
of apoptosis such as chromatin margination (Fig. 4 A), chromatin condensation    
(Fig. 4 C) and formation of apoptotic bodies. The presence of apoptotic bodies (Fig. 4 E), 
nuclear shrinkage and DNA fragmentation were also observed at 7 days post injury. 
A few necrotic cells were also recognized (Fig. 4 E). The corresponding views of the 
identical cells are shown for HO33342 staining and reveal that apoptotic cells were 
surrounded by cells with normal nuclear morphology which might either be not 
affected by the trauma or might just be in a very early state of cell death (Fig. 4 B, D 
and F, respectively). 
 
4.3. TUNEL positive cells co-localize with neuronal marker NeuN-, Fas- and 
FasL immunoreactivity 
 The cell types susceptible to degeneration following CHI were identified by 
TUNEL/HO33342 double staining in conjunction with IHC, using anti-NeuN, -PMN 
and -CD11b antibodies on consecutive brain sections as respective markers for 
neurons, neutrophils and macrophages/activated microglia. TUNEL positive cells 
were detected in the injured cortex (Fig. 5 A) and the ipsilateral CA2/3 hippocampal 
regions (Fig. 5 E). They co-localized mostly with neurons (Fig. 5 B and F, 
respectively) as well as with Fas- (Fig. 5 C and G, respectively) and FasL expressing 
cells (Fig. 5 D and H, respectively) at 24 hours after CHI. At 7 days post trauma, 
there were virtually no TUNEL positive cells in the ipsilateral hippocampus (Fig. 5 I). 
Interestingly, we have discovered a marked overall loss of cells in both the ipsilateral 
hippocampus (Fig. 5 J - L) and injured cortex (not shown) at 7 days following CHI in 
the corresponding areas that showed extensive cell death by TUNEL staining at      
24 hours. No TUNEL positive cells were found either in the contralateral hemispheres 
or in the brains of control animals (not shown). 
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4.4. Fas expression after closed head injury 
 Immunohistochemical analysis of normal wild type and sham-operated mice of 
all strains revealed that Fas was constitutively expressed at moderate levels in the 
cortex (Fig. 6 A, Table 2), hippocampus (Fig. 6 G, Table 2) and thalamus (Table 2). 
At 24 hours after CHI, Fas expression was clearly elevated in the injured cortex   
(Fig. 6 C, Table 2), hippocampus (Fig. 6 I, Table 2) and thalamus (Table 2) when 
compared to sham-operated control mice. Maximal Fas expression was detected in 
the ipsilateral cortex near the administered CHI in both IL-6 / (Fig. 6 C, Table 2) 
and TNF/LT- / mice (Table 2) at 24 hours after CHI. In all mouse strains, we also 
found an evident increase in the expression of Fas in the ipsilateral hippocampal 
CA2/3 regions (Fig. 6 I) at 24 hours after CHI when compared to sham-operated 
mice. Fas expression was also elevated in the ipsilateral thalamus of both      
TNF/LT- / and IL-6 / mice (Table 2) at 24 hours after CHI. At 7 days post injury, 
there was a trend of Fas expression to return to base levels in the cortex of mice of 
the B6x129 strain (TNF/LT- / and wild type) (Table 2) whereas it remained at a 
slightly higher level in the cortex of mice of the B6 strain (IL-6 / and wild type;    
Fig. 6 E, Table 2). In the hippocampus, Fas expression decreased to base levels in 
both strains at 7 days following brain injury (Fig. 6 K, Table 2). In the thalamus, 
variations in immunoreactivity were generally of lower levels among the different 
mouse strains, at the points in time measured. When compared to the respective 
control animals, Fas remained upregulated in the thalamus of B6x129 mice (Table 2) 
while it returned to base levels in B6, IL-6 / and TNF/LT- / mice at 7 days 
following CHI (Table 2). 
 
4.5. FasL expression after closed head injury 
 Contrary to the constitutive expression observed for Fas, no evident base FasL 
immunoreactivity was detected in the cortex (Fig. 6 B, Table 2), hippocampus (Fig. 6 H, 
Table 2) or thalamus (Table 2) of sham-operated or uninjured control mice. At 24 hours 
following CHI, FasL was moderately increased in the ipsilateral cortex of both the 
B6x129 mouse strain (TNF/LT- / and wild type; Table 2) and, to a lesser extent, 
the B6 mouse strain (IL-6 / and wild type; Fig. 6 D, Table 2) when compared to 
control mice. A slightly elevated FasL expression was also observed at 24 hours post 
injury in the ipsilateral hippocampus of IL-6 / mice (Fig. 6 J, Table 2) and their B6 
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wild type littermates, but neither in TNF/LT- / nor in B6x129 mice. The ipsilateral 
thalamus showed moderate FasL expression in mice of the B6 mouse strain and 
slight FasL expression in TNF/LT- / mice at 24 hours after trauma (Table 2). 
Generally, the extent of FasL expression in mice from different genetic backgrounds 
showed only minor differences when compared at 24 hours post injury. Interestingly, 
FasL reached maximal levels at 7 days post injury, to a similar extent in the cortex of 
all mice subjected to CHI (Fig. 6 F, Table 2). A moderate FasL immunoreactivity was 
observed in the ipsilateral thalamus (Table 2), but almost no positive FasL signal was 
found in the ipsilateral hippocampus (Fig. 6 L, Table 2) at 7 days post injury. 
 
4.6. Posttraumatic cerebral accumulation of PMNs and macrophages/ 
activated microglia 
 Experimental CHI induced a marked accumulation of PMNs and 
macrophages/activated microglia within the injured hemisphere, as shown by IHC 
using anti-PMN and anti-CD11b antibodies, respectively, in Figure 7. For 
quantification, the percentage of both PMNs and CD11b positive cells was calculated 
with respect to the total number of cells counterstained with methyl green. In both / 
and wild type mouse groups, the extent of PMNs as well as of CD11b positive cells 
was highest in the injured cortex near the site of trauma at 24 hours and it clearly 
decreased at 7 days post injury (Fig. 7 A and B). These values were generally similar 
between TNF/LT- / and B6x129 mice, while a notedly elevated difference in the 
percentage of infiltrating PMNs was found at 24 hours when comparing IL-6 / mice 
to their B6 wild type littermates (21.4% ± 4.3% and 12.7% ± 2.3%, respectively;     
Fig. 7 A). By 7 days after trauma, the percentage of both PMNs and CD11b positive 
cells did not differ among the genetic different groups but was significantly lower 
when compared to the corresponding values at 24 hours post injury (Fig. 7 A and B; 
Student's t-test, p<0.05). Only very few PMNs or CD11b positive cells were found in 
sham-operated control animals (Fig. 7 A, B, C and D, respectively) or in the 
contralateral hemispheres (not shown). At 24 hours after CHI, besides massive 
accumulation of PMNs and presence of CD11b positive cells in the directly contused 
cortex, inflammatory cells were also present in the deeper layers of the injured cortex 
describing an uniform pattern of cells in both stainings (Fig. 7 E and G), suggesting a 
strong influence by the mechanisms of secondary brain injury. PMNs were found 
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located intravascularly as well as in the proximity of blood vessels, suggesting 
intrathecal extravasation (Fig. 7 F). Furthermore, CD11b positive cells were detected 
in the ipsilateral corpus callosum at 24 hours (Fig. 7 G). The amount of PMNs and 
CD11b positive cells decreased but could still be found at 7 days post injury (Fig. 7 H 
and I, respectively). 
  19 
5. Discussion 
  
 
 
 The model of experimental CHI used in this study produced extensive and 
prolonged damage in the ipsilateral hemisphere, including abundant DNA 
degradation, widened contusion cavity and enlarged ventricles, which is consistent 
with observations previously reported in this model (Shapira et al., 1988; Chen et al., 
1996). We found evidence that a large number of TUNEL positive nuclei were 
present in the injured cortex and, to a minor degree, in the ipsilateral hippocampus at 
the CA2/3 regions. Maximal values for TUNEL positive cells were found within the 
acute phase (24 hours) in the cortex near the site of impact and, to a lesser degree, 
at 7 days after CHI. In the ipsilateral hippocampus, TUNEL positive cells were 
detected in the CA2/3 regions at 24 hours but not at 7 days. The nuclei of TUNEL 
positive cells showed morphological features of both apoptosis and necrosis, 
supporting the premise that both mechanisms of cell death occur simultaneously 
after experimental TBI (Charriaut-Marlangue and Ben-Ari, 1995; Grasl-Kraupp et al., 
1995; Kato et al., 1997). Our results suggest that CHI generates a pattern of 
neuronal cell death in different brain regions similar to that described in previous 
studies using either this or other models of TBI (Shapira et al., 1993; Pravdenkova et al., 
1996; Tang et al., 1997), cortical contusion (Baldwin et al., 1997), controlled cortical 
impact (Colicos and Dash, 1996; Clark et al., 1997b), lateral fluid-percussion brain 
injury (Rink et al., 1995; Yakovlev et al., 1997; Conti et al., 1998; Knoblach et al., 
1999) and cortical cryolesion (Tominaga et al., 1992). It is also important to mention 
that the percentage of dead cells was slightly increased in the brain of TNF/LT- / 
mice and their respective wild type littermates when compared to IL-6 / mice and 
the corresponding wild type littermates at 24 hours following CHI, as previously 
reported by our group (Stahel et al., 2000). Generally, the total amount of cortical 
cells decreased at 7 days post injury when compared to corresponding brain regions 
at 24 hours after injury, as assessed by methyl green- and H&E staining. A marked 
neuronal loss was found within the injured brain areas at both points in time 24 hours 
and 7 days post trauma when compared to sham-operated control mice. 
 
In the present study, we identified most of the TUNEL-, Fas- and FasL positive cells 
to be neurons according to the co-localizing immunoreactivity with NeuN antibodies. 
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Dying neurons showed the typical morphological features of apoptosis such as 
chromatin margination and condensation, nuclear shrinkage and formation of 
apoptotic bodies at both 24 hours and 7 days after CHI. The evident neuronal loss 
observed in the CA2/3 regions of the ipsilateral hippocampus clearly indicates that 
this subgroup of neurons is sensitive to Fas-mediated apoptosis at early stages and 
is likely to degenerate via secondary molecular mechanisms triggered by the primary 
injury in the adjacent cortex. These findings support the evidence that neuronal cell 
death continues as a chronic process after brain trauma, shifting from the directly 
contused area into adjoining areas and other proximal regions, as previously 
reported (Colicos and Dash, 1996; Shohami et al., 1996; Tang et al., 1997; Baldwin 
et al., 1997; Clark et al., 1997b; Conti et al., 1998). 
 
Unlike FasL, constitutive Fas expression in cortical and hippocampal neurons was 
described earlier on the normal mouse brain (Park et al., 1998). However, increased 
expression of both Fas and FasL were demonstrated in studies on experimental and 
clinical TBI. Fas and FasL were both localized on cortical neurons and astrocytes of 
brains of rats for up to 72 hours after injury (Beer et al., 2000), while in patients an 
elevation of sFas and FasL was detected in the CSF for several days following 
severe head trauma (Ertel et al., 1997; Lenzlinger et al., 2001). In accordance with 
other studies, our findings show a strong expression of Fas protein occurring at 24 hours 
in the injured cortex and in the ipsilateral hippocampal CA2/3 regions in mice 
subjected to CHI. Fas expression was slightly stronger in mice lacking the 
inflammatory cytokines TNF, LT- or IL-6 when compared to the respective wild type 
littermates. However, this difference was determined by a semi-quantitative analysis 
and its significance cannot be proven statistically. At 7 days after CHI, Fas remained 
moderately upregulated in mice of the B6 genetic background (IL-6 / and wild type) 
while it returned to constitutive levels in the B6x129 strain (TNF/LT- / and wild 
type). Altogether, these findings suggest that Fas might be involved in the 
degeneration of neurons in the cortex since its expression coincides with the highest 
incidence of cell death within the first 24 hours post injury. CA2/3 hippocampal 
neurons are also sensitive to Fas-mediated cell death at early stages and are likely to 
degenerate by apoptosis. 
 
  21 
With regard to FasL, we did not find any evidence of constitutive level of expression 
in the brain sections of control mice. However, 24 hours after CHI, FasL was slightly 
upregulated in both the cortex near the site of trauma (all mouse strains) and the 
ipsilateral thalamus (IL-6 / mice and their respective wild type animals). To a lesser 
extent, FasL was also localized on ipsilateral CA2/3 hippocampal neurons of IL-6 / 
mice and the respective wild type littermates at 24 hours post injury. Maximal 
expression of FasL was detected in the cortex of all animals subjected to CHI at 7 days 
when compared to animals sacrificed at 24 hours post injury. This data suggests that 
FasL may be involved in mechanisms of delayed neurodegeneration. 
 
Surprisingly, maximal upregulation of both Fas and FasL did not occur 
simultaneously. It can be assumed that FasL might be the modulating key factor 
determining the onset of the apoptotic cascade since a slight increase of its 
expression beginning within the first 24 hours following injury seems to be sufficient 
to induce neuronal apoptosis through the binding to Fas receptor expressed at either 
constitutive or increased levels. It is conceivable that once it reaches maximal 
concentrations at 24 hours, Fas may be cleaved into the soluble form sFas, thus 
suppressing subsequent cell death by competing with the membrane-bound receptor 
and thus blocking the action of FasL (Cheng et al., 1994). On the contrary, an 
increased secretion of sFasL may enhance cell death. Therefore, the balance 
between Fas- and FasL levels in either the membrane-bound or soluble form seems 
to be crucial for initiating or suppressing apoptosis. 
 
It is a matter of controversy whether the posttraumatic inflammation contributes to 
secondary brain damage and delayed neurodegeneration. As previously described in 
various models of TBI, maximal accumulation of leukocytes was detected within the 
lesion 24 hours post injury (Biagas et al., 1992; Shapira et al., 1993; Clark et al. 
1994; Stahel et al. 2000). In this study, we show that the accumulation of PMNs and 
macrophages/activated microglia (CD11b positive) was maximal in the injured 
hemisphere at 24 hours after CHI in all animal groups and that, although attenuated, 
was still increased at 7 days. As we did not find an obvious difference in the 
accumulation of PMNs and CD11b positive cells between cytokine / and wild type 
mice, we cannot demonstrate an evident role for TNF, LT- or IL-6 in mediating 
cerebral leukocyte accumulation. Based on the fact that leukocyte recruitment 
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preceded the upregulation of FasL, it can be speculated that cell death may be 
mediated by alternative mechanisms that require further study. To this regard, it has 
been previously reported that FasL, amongst others, is a potent chemoattractant for 
neutrophils and may thus sustain their accumulation and the release of other 
neurotoxic molecules in the injured brain (Ottonello et al. 1999). 
 
In conclusion, the lack of evident differences in the expression of Fas and FasL 
between cytokine / and wild type mice indicates that TNF, LT- and IL-6 may not 
play a significant role in the regulation of Fas-mediated neuronal death. However, 
independent of the impact of cytokines on its expression, our data clearly shows that 
the Fas/FasL system seems to be involved in neuronal cell death following brain 
injury. Additional studies need to be undertaken to assess a conclusive significance 
of the role of inflammation in neurodegenerative processes occurring within the acute 
and delayed phases after TBI. 
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6. Appendix 1: Tables 
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Table 1.  Differential features and significance of apoptosis and necrosis. 
 
Apoptosis  Necrosis 
    Morphological features 
Membrane blebbing, but no loss of integrity 
Begins with shrinkage of cytoplasm and 
condensation of nucleus 
Ends with fragmentation of cell into smaller 
bodies 
Aggregation of chromatin at the nuclear 
membrane 
Formation of membrane bound vesicles 
(apoptotic bodies) 
Mitochondria become leaky due to pore 
formation involving proteins of the bcl-2 family 
  Loss of membrane integrity 
 Begins with swelling of cytoplasm and 
mitochondria 
 Ends with total cell lysis 
 No vesicle formation, complete lysis 
 Disintegration (swelling) of organelles 
    Biochemical features 
Tightly regulated process involving activation 
and enzymatic steps 
Energy (ATP)-dependent (active process, 
does not occur at 4°C) 
Non random mono- and oligonucleosomal 
length fragmentation of DNA (ladder pattern 
after agarose gel electrophoresis) 
Prelytic DNA fragmentation 
Activation of caspase cascade 
Alterations in membrane asymmetry         (e.g. 
translocation of phosphatidylserine from the 
cytoplasmic to the extracellular side of the 
membrane) 
  Loss of regulation of ion homeostasis 
 No energy requirement (passive process, 
also occurs at 4°C) 
 Random digestion of DNA (smear of DNA 
after agarose gel electrophoresis) 
 Postlytic DNA fragmentation (late event of 
death) 
    Physiological significance 
Affects individual cells 
Induced by physiological stimuli            
(death factors, lack of growth factors, 
changes in hormonal environment) 
Phagocytosis by adjacent cells or 
macrophages 
  Affects groups of contigous cells 
 Evoked by non physiological disturbances 
(complement attack, lytic viruses, 
hypothermia, hypoxia, ischemia, metabolic 
poisons) or mechanical destruction 
 Phagocytosis by macrophages 
 Table 2.  Relative number and distribution patterns of Fas- and FasL immunoreactivity in the injured mice brains. 
 
Mice n Condition Fas expression  FasL expression 
   Cortex Hippocampus CA2/3 Thalamus  Cortex Hippocampus CA2/3 Thalamus 
Control 8 Normal and SHAM-OP ++ ++ ++     
          
TNF/LT- / 3 CHI, t = 24 hours ++++ +++ +++  ++  + 
B6x129 3 CHI, t = 24 hours +++ +++ ++  ++   
          
TNF/LT- / 4 CHI, t = 7 days ++ ++ ++  +++  + 
B6x129 4 CHI, t = 7 days ++ ++ +++  +++ + + 
          
IL-6 / 3 CHI, t = 24 hours ++++ +++ +++  + + ++ 
B6 4 CHI, t = 24 hours +++ +++ ++  + + ++ 
          
IL-6 / 4 CHI, t = 7 days +++ ++ ++  +++  ++ 
B6 4 CHI, t = 7 days +++ ++ ++  +++  ++ 
 
Posttraumatic Fas- and FasL expression in the injured left hemisphere of TNF/LT- / and IL-6 / mice and their respective wild type littermates at 24 hours 
and 7 days after experimental CHI. The relative number of both Fas- and FasL positive cells was semi-quantitatively assessed in the cortex, hippocampus and 
thalamus and was expressed as follows: , no positive cells; +, few positive cells (<10%); ++, 10% to 50% positive cells; +++, 50% to 90% positive cells; 
++++, 90% to 100% positive cells. CHI: closed head injury, SHAM-OP: sham-operated, CA2/3: hippocampus CA2/3 region of Ammon's horn,               
TNF/LT- /: mice deficient in genes for TNF and LT-, B6x129: C57BL/6x129Sv/Ev wild type mice, IL-6 /: mice deficient in genes for IL-6,                     
B6: C57BL/6 wild type mice, control: normal wild type mice and B6x129-, B6-, TNF/LT- / and IL-6 / sham-operated mice. 
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7. Appendix 2: Figures 
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Figure 1. Electric weight drop device to apply a focal closed head injury to mice brains. A metal rod of 333 g falling from a height of 2 cm
induces a focal brain trauma (A). The trauma is induced to the left hemisphere 2 mm lateral to the midline of the brain in the midcoronal
plane. A silicone tip is fixed at the end of the impacting rod in order to avoid penetrating skull fractures (B).
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Figure 2. Macroscopic presentation of an injured mouse brain. A representative fronto-caudal coronal view of an
injured left hemisphere of a B6 –/– mouse sacrificed at 24 hours after CHI is shown during the process of performing
cryosections. The brain is frozen and embedded in OCT compound. Note the contusion cavity (CAV) at the site of
trauma and the underlying injured cortex (IC, within dotted line). Circle: position of the CA2/3 regions of the
hippocampus, quadrate: position of the thalamus, ML: midline of the brain. Original magnification: 8.
IC
Figure 3. Cell death in the mouse brain following closed head injury. Brain sections of 10 µm were analyzed at 24
hours and 7 days after CHI using TUNEL/HO33342 fluorescence double staining. Representative photomicrographs
are shown for B6 –/– mice and demonstrate pairs of identical fields using different UV filters. The left column shows
TUNEL staining: cortex at 24 hours after sham operation (A) and at 24 hours after CHI (C), hippocampus at 24 hours
after CHI (E) and cortex at 7 days after CHI (G). Note the maximal elevation of TUNEL positive cells in and adjacent
to the directly contused cortex (CC) at 24 hours (C) and the decreased extent of cell death at 7 days following CHI
(G). The right column displays the total amount of cells by HO33342 staining (B, D, F and H) in the identical fields as
shown for TUNEL staining. The arrowheads point to deeper cortical layers not directly contused by the impact. The
arrows point towards the brain surface. CHI: closed head injury, SHAM-OP: sham-operated, Hippoc.: hippocampus,
CAV: contusion cavity, VE: ventricle. Original magnification: 250, except E and F (500).
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Figure 4. Apoptosis in the injured cortex. High magnification photomicrographs
of the cortical layer IV of mice subjected to CHI show TUNEL (A, C and E) and
HO33342 (B, D and F) fluorescence double staining in identical fields
representatively for B6 –/– mice. Note the presence of chromatin margination and
condensation at 24 hours after CHI (A - D, thin arrows and thick arrows,
respectively). The formation of apoptotic bodies is shown here at 7 days after CHI
(E and F; arrowheads). Necrotic cells depict nuclei with diffuse staining (E and F;
double arrows) as shown at 7 days post injury. TUNEL: terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP nick end labeling, HO33342: bisbenzimide
Hoechst 33342 fluorochrome. Original magnification: 1250.
Figure 5. TUNEL positive cells co-localize with neuronal marker NeuN-, Fas- and FasL immunoreactivity. (legend: see next page)
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Figure 5. TUNEL positive cells co-localize with neuronal marker NeuN-, Fas- and 
FasL immunoreactivity. Mice were sacrificed at 24 hours and 7 days after CHI for 
analysis, as described in the text. Photomicrographs show staining for TUNEL        
(A, E and I), NeuN (B, F and J), Fas (C, G and K) and FasL (D, H and L) on 
consecutive ipsilateral brain sections representatively for B6 / mice. The first row 
(A - D) shows staining of the cortex at 24 hours after CHI. The second (E - H) and 
third (I - L) row show staining of the hippocampus at 24 hours and 7 days post injury. 
Most of the cells positive for TUNEL staining were identified as neurons according to 
the expression of NeuN (arrows, representatively shown in the views for the cortex). 
These cells also expressed Fas- and FasL, as demonstrated by 
immunohistochemistry with specific antibodies on adjacent brain sections. Only a few 
hippocampal neurons were labeled by TUNEL staining at 24 hours (E), whereas 
virtually no TUNEL positive cells were found in the hippocampus at 7 days post injury (I). 
CHI: closed head injury. Original magnification: 125X, except A - D (1000X). 
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Figure 6. Immunolabeling for Fas and FasL in the injured hemisphere.
(legend: see next page)
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Figure 6. Immunolabeling for Fas and FasL in the injured hemisphere. 10 m thick 
consecutive coronal brain sections were analyzed at 24 hours following sham 
operation or CHI and at 7 days following CHI. Representative photomicrographs for 
IL-6 / mice show neurons of the cortex and hippocampus stained for anti-Fas 
antibody (left column) and anti-FasL antibody (right column). The first part of the 
figure (A - F) shows staining of the cortex of sham-operated control mice (A and B) 
as well as of mice at 24 hours (C and D) and 7 days (E and F) after CHI. The second 
part of the figure (G - L) represents the hippocampal CA2/3 regions of sham-operated 
control mice (G and H) as well as at 24 hours (I and J) and 7 days (K and L) after 
CHI. Note the constitutive expression of Fas in the cortex (A) and hippocampus (G) 
of control mice and the markedly increased amount of stained cells at 24 hours in the 
cortex (C) and hippocampus (I) followed by a decrease at 7 days after CHI (E and K, 
respectively). In contrast, FasL was virtually undetectable in control brains (B and H), 
was slightly upregulated in the injured brains at 24 hours (D and J) and reached 
maximal upregulation at 7 days (F and L) after CHI. CHI: closed head injury,    
SHAM-OP: sham-operated. Original magnification: 500X. 
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Figure 7. Accumulated PMNs and macrophages/activated microglia in the injured mouse brain. Serial coronal brain
sections of sham-operated mice as well as of mice sacrificed at 24 hours and 7 days after CHI were labeled with
anti-PMN- (left column) and anti-CD11b (macrophages/activated microglia; right column) antibodies, respectively.
Representative photomicrographs of injured hemispheres of B6 –/– mice are shown. The relative number of accumulated
PMNs and CD11b positive cells were calculated and their mean values ± SD are shown in the panels A and B.
Virtually no PMNs or CD11b positive cells were shown in sham-operated mice (A, B and C, D) whereas a marked
accumulation of PMNs and CD11b positive cells was found within the injured hemisphere at 24 hours (E and G) and,
to a lesser extent, at 7 days (H and I) following CHI. The inset F shows the presence of both intravascular (thick arrow)
and perivascular PMNs. The thin arrows point towards the brain surface. SHAM-OP: sham-operated, –/–: knockout,
IC: injured cortex, CAV: contusion cavity, VE: ventricle, SD: standard deviation. *p<0.05 versus 7 days (Student's t-test).
Original magnification: 125, except F (500).
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8. Abbreviations 
  
 
 
ATP = adenosine triphosphate 
APO-1 = Fas 
APO-1L = Fas ligand 
B6 = C57BL/6 genetic background 
B6x129 = C57BL/6x129Sv/Ev genetic background 
BBB = blood-brain barrier 
CA2/3 = CA2/3 regions of cornu Ammonis (Ammon's horn) 
CAV = contusion cavity 
CC = contused cortex 
CD11b = cluster of determination 11b 
CD95 = Fas 
CD95L = Fas ligand 
CHI = closed head injury 
CNS = central nervous system 
CSF = cerebrospinal fluid 
DNA = desoxyribonucleic acid 
Fas = a member of the TNF receptor family that is expressed on 
the surface of many cell types and initiates a signaling 
cascade leading to apoptotic death of the cell 
FasL = Fas ligand, a member of the TNF ligand family that induces 
apoptosis via the death receptor Fas 
H&E = Hematoxylin and Eosin 
HO33342 = bisbenzimide Hoechst 33342 nucleic acid staining 
IC = injured cortex 
IHC = immunohistochemistry 
IL = interleukin 
LT = lymphotoxin 
M = mole 
ML = midline 
NeuN = Neuronal Nuclei, vertebrate neuron-specific nuclear protein 
NSE = neuron-specific enolase 
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NGF = nerve growth factor 
PBS = phosphate buffered saline 
PCD = programmed cell death 
PMN = polymorphonuclear leukocyte 
RT = room temperature 
SD = standard deviation 
sFas = soluble Fas 
sFasL = soluble FasL 
SHAM-OP = sham-operated 
TBI = traumatic brain injury 
TdT = terminal deoxynucleotidyl transferase 
TNF = tumor necrosis factor 
TUNEL = terminal deoxynucleotidyl transferase (TdT)-mediated dUTP 
nick end labeling 
VE = ventricle 
/ = knockout 
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